Cargando…

Impact of VMAT-IMRT compared to 3D conformal radiotherapy on anal sphincter dose distribution in neoadjuvant chemoradiation of rectal cancer

BACKGROUND: Neoadjuvant radio- or chemoradiation (nIRT) therapy is the standard treatment for loco-regional advanced rectal cancer patients of the lower or middle third. Currently, intensity modulated radiation therapy (IMRT) is not the recommended radiation technique even though IMRT has advantages...

Descripción completa

Detalles Bibliográficos
Autores principales: Dapper, Hendrik, Rodríguez, Iván, Münch, Stefan, Peeken, Jan C., Borm, Kai, Combs, Stephanie E., Habermehl, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276230/
https://www.ncbi.nlm.nih.gov/pubmed/30509284
http://dx.doi.org/10.1186/s13014-018-1187-7
_version_ 1783377973945040896
author Dapper, Hendrik
Rodríguez, Iván
Münch, Stefan
Peeken, Jan C.
Borm, Kai
Combs, Stephanie E.
Habermehl, Daniel
author_facet Dapper, Hendrik
Rodríguez, Iván
Münch, Stefan
Peeken, Jan C.
Borm, Kai
Combs, Stephanie E.
Habermehl, Daniel
author_sort Dapper, Hendrik
collection PubMed
description BACKGROUND: Neoadjuvant radio- or chemoradiation (nIRT) therapy is the standard treatment for loco-regional advanced rectal cancer patients of the lower or middle third. Currently, intensity modulated radiation therapy (IMRT) is not the recommended radiation technique even though IMRT has advantages compared to 3D-radiation regarding dose sparing to organs at risk like small bowel and urinary bladder. So far, the benefit of IMRT concerning the anal sphincter complex is not examined. With this study we intended to evaluate the dose distribution on the anal sphincters of rectal cancer patients treated with IMRT in comparison with 3D-techniques. METHODS: We selected 16 patients for the IMRT-group and 16 patients for the 3D-group with rectal cancer of the middle third who were treated in our institute. All patients received 45 Gy in a chemoradiation protocol. Patients in both groups were matched regarding stage, primary tumor distance to the anal verge and size of the tumor. We delineated the internal and external anal sphincters, the addition of both sphincters and the levator ani muscle in all patients. Subsequently, we evaluated and compared dose parameters of the different sphincters in both groups and analysed the configuration of the isodoses in the area of the caudal radiation field, respectively. RESULTS: Most of the relevant dose parameters of the caudal sphincters (Dmean, Dmedian, V10–V40) were significantly reduced in the IMRT-group compared to the 3D-group. Accordingly, the isodoses at the caudal edge of the target volume in the IMRT group demonstrated a steep dose fall. The levator ani muscle always was included into the planned target volumes and received the full dose in both groups. CONCLUSIONS: The modern VMAT-IMRT can significantly reduce the dose to the anal sphincters for rectal cancer patients of the middle third who were treated with conventional chemoradiation therapy.
format Online
Article
Text
id pubmed-6276230
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-62762302018-12-06 Impact of VMAT-IMRT compared to 3D conformal radiotherapy on anal sphincter dose distribution in neoadjuvant chemoradiation of rectal cancer Dapper, Hendrik Rodríguez, Iván Münch, Stefan Peeken, Jan C. Borm, Kai Combs, Stephanie E. Habermehl, Daniel Radiat Oncol Research BACKGROUND: Neoadjuvant radio- or chemoradiation (nIRT) therapy is the standard treatment for loco-regional advanced rectal cancer patients of the lower or middle third. Currently, intensity modulated radiation therapy (IMRT) is not the recommended radiation technique even though IMRT has advantages compared to 3D-radiation regarding dose sparing to organs at risk like small bowel and urinary bladder. So far, the benefit of IMRT concerning the anal sphincter complex is not examined. With this study we intended to evaluate the dose distribution on the anal sphincters of rectal cancer patients treated with IMRT in comparison with 3D-techniques. METHODS: We selected 16 patients for the IMRT-group and 16 patients for the 3D-group with rectal cancer of the middle third who were treated in our institute. All patients received 45 Gy in a chemoradiation protocol. Patients in both groups were matched regarding stage, primary tumor distance to the anal verge and size of the tumor. We delineated the internal and external anal sphincters, the addition of both sphincters and the levator ani muscle in all patients. Subsequently, we evaluated and compared dose parameters of the different sphincters in both groups and analysed the configuration of the isodoses in the area of the caudal radiation field, respectively. RESULTS: Most of the relevant dose parameters of the caudal sphincters (Dmean, Dmedian, V10–V40) were significantly reduced in the IMRT-group compared to the 3D-group. Accordingly, the isodoses at the caudal edge of the target volume in the IMRT group demonstrated a steep dose fall. The levator ani muscle always was included into the planned target volumes and received the full dose in both groups. CONCLUSIONS: The modern VMAT-IMRT can significantly reduce the dose to the anal sphincters for rectal cancer patients of the middle third who were treated with conventional chemoradiation therapy. BioMed Central 2018-12-03 /pmc/articles/PMC6276230/ /pubmed/30509284 http://dx.doi.org/10.1186/s13014-018-1187-7 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Dapper, Hendrik
Rodríguez, Iván
Münch, Stefan
Peeken, Jan C.
Borm, Kai
Combs, Stephanie E.
Habermehl, Daniel
Impact of VMAT-IMRT compared to 3D conformal radiotherapy on anal sphincter dose distribution in neoadjuvant chemoradiation of rectal cancer
title Impact of VMAT-IMRT compared to 3D conformal radiotherapy on anal sphincter dose distribution in neoadjuvant chemoradiation of rectal cancer
title_full Impact of VMAT-IMRT compared to 3D conformal radiotherapy on anal sphincter dose distribution in neoadjuvant chemoradiation of rectal cancer
title_fullStr Impact of VMAT-IMRT compared to 3D conformal radiotherapy on anal sphincter dose distribution in neoadjuvant chemoradiation of rectal cancer
title_full_unstemmed Impact of VMAT-IMRT compared to 3D conformal radiotherapy on anal sphincter dose distribution in neoadjuvant chemoradiation of rectal cancer
title_short Impact of VMAT-IMRT compared to 3D conformal radiotherapy on anal sphincter dose distribution in neoadjuvant chemoradiation of rectal cancer
title_sort impact of vmat-imrt compared to 3d conformal radiotherapy on anal sphincter dose distribution in neoadjuvant chemoradiation of rectal cancer
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276230/
https://www.ncbi.nlm.nih.gov/pubmed/30509284
http://dx.doi.org/10.1186/s13014-018-1187-7
work_keys_str_mv AT dapperhendrik impactofvmatimrtcomparedto3dconformalradiotherapyonanalsphincterdosedistributioninneoadjuvantchemoradiationofrectalcancer
AT rodriguezivan impactofvmatimrtcomparedto3dconformalradiotherapyonanalsphincterdosedistributioninneoadjuvantchemoradiationofrectalcancer
AT munchstefan impactofvmatimrtcomparedto3dconformalradiotherapyonanalsphincterdosedistributioninneoadjuvantchemoradiationofrectalcancer
AT peekenjanc impactofvmatimrtcomparedto3dconformalradiotherapyonanalsphincterdosedistributioninneoadjuvantchemoradiationofrectalcancer
AT bormkai impactofvmatimrtcomparedto3dconformalradiotherapyonanalsphincterdosedistributioninneoadjuvantchemoradiationofrectalcancer
AT combsstephaniee impactofvmatimrtcomparedto3dconformalradiotherapyonanalsphincterdosedistributioninneoadjuvantchemoradiationofrectalcancer
AT habermehldaniel impactofvmatimrtcomparedto3dconformalradiotherapyonanalsphincterdosedistributioninneoadjuvantchemoradiationofrectalcancer